OPALEYE MANAGEMENT INC. purchased 2.2% of their position (60.49K shares) of GRACE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $123.8K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 10/5/2026ACC: 0001493152-26-045809
10% Owner
Since Aug 2026
+60.49K
Net shares
Net buyer
$123.8K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
60.49K acquired
Non-Derivative Transactions3
Common Stock, par value $0.0001 per share
Indirect
Shares
+38.80K
Price / share
$2.04
Trade value
$78.96K
% of position
1.4%
10/1/2026
2.80M→2.84M
Common Stock, par value $0.0001 per share
Indirect
Shares
+20K
Price / share
$2.07
Trade value
$41.37K
% of position
0.7%
10/2/2026
2.84M→2.86M
Common Stock, par value $0.0001 per share
Indirect
Shares
+1.69K
Price / share
$2.06
Trade value
$3.49K
% of position
0.1%
10/5/2026
2.86M→2.86M
Total
Net shares
+60.49K
Net value
$123.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Indirect | 10/1/2026 | P · Purchase | +38.80K | $2.04 | $78.96K | 1.4% | 2.80M | 2.84M |
| Common Stock, par value $0.0001 per share Indirect | 10/2/2026 | P · Purchase | +20K | $2.07 | $41.37K | 0.7% | 2.84M | 2.86M |
| Common Stock, par value $0.0001 per share Indirect | 10/5/2026 | P · Purchase | +1.69K | $2.06 | $3.49K | 0.1% | 2.86M | 2.86M |
| Total | +60.49K | $123.82K | ||||||
Derivative Transactions0
No derivative transactions reported